首頁 > 市場調查報告書 > 製藥

疼痛

對乙醯胺酚市場規模、佔有率和成長分析（按類型、劑型、應用、最終用戶、分銷管道和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1898358

對乙醯胺酚市場規模、佔有率和成長分析（按類型、劑型、應用、最終用戶、分銷管道和地區分類）—產業預測，2026-2033年

Paracetamol Market Size, Share, and Growth Analysis, By Type (Veterinary Drug Grade and Acetaminophen Grade), By Formulation (Tablet, Capsule), By Application, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 182 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球乙醯胺酚市場規模將達到 7.9521 億美元，到 2025 年將成長至 8.302 億美元，到 2033 年將成長至 11.7163 億美元，預測期（2026-2033 年）的複合成長率為 4.4%。

全球乙醯胺酚市場正經歷顯著成長，主要受消費者日益成長的自我用藥意願以及發燒、疼痛和頭痛等輕微健康問題增加的推動。乙醯胺酚的可及性、價格優勢以及其作為基本藥物的地位，進一步促進了這一趨勢。新興經濟體醫療基礎設施的加強正在提升乙醯胺酚的供應。然而，嚴格的法規環境和品質問題等挑戰正在影響相關人員，導致生產成本上升和上市時間延長。不當使用問題凸顯了加強消費者教育和強化監管以確保安全的重要性。儘管存在這些障礙，但製劑創新，例如副作用較少的藥物和特殊用途產品，正在帶來新的機會。合作與分銷網路的拓展顯示市場具有持續擴張的潛力。

全球乙醯胺酚市場按類型、製劑形式、應用、最終用戶、通路和地區進行細分。依類型分類，分為對乙醯胺酚級和動物用藥品級。依製劑形式，分為其他、粉末、液體混懸劑、膠囊及錠劑。按應用分類，分為其他、緩解感冒和流感、退燒和止痛。按最終用戶分類，分為醫院、診所、居家醫療和門診手術中心。依通路分類，分為零售藥局、醫院藥局、網路藥局及超級市場/大賣場。按地區分類，本研究涵蓋北美、歐洲、亞太地區、中東和非洲以及拉丁美洲。

全球乙醯胺酚市場促進因素

全球乙醯胺酚市場成長的主要驅動力是關節炎、偏頭痛和腰痛等疼痛相關疾病的日益增加。相當一部分成年人患有慢性疼痛，凸顯了有效疼痛管理方案的迫切需求。為了應對這一日益嚴峻的問題，許多政府和醫療機構都在倡導改善疼痛緩解措施的可近性。對慢性疼痛問題的日益關注不僅推高了對乙醯胺酚的需求，也促進了旨在改善疼痛管理策略的製定，從而進一步推動了市場成長，並擴大了其在不同人群中的覆蓋範圍。

限制全球乙醯胺酚市場的因素

由於人們持續擔憂過量服用對乙醯氨基酚的風險，全球對乙醯胺酚市場面臨巨大的限制。包括主要監管機構在內的世界各地衛生組織已發出警告，指出過量服用對乙醯胺酚可能肝功能衰竭。這種令人擔憂的關聯使得過量服用對乙醯氨基酚成為肝臟相關健康問題的主要原因之一。這促使製藥業訂定了更嚴格的法規並加強了安全通訊協定。為了應對這些挑戰，GlaxoSmithKline Plc等公司正在採取積極措施，提高安全標準，降低對乙醯胺酚使用相關的風險，最終影響市場動態。

全球乙醯胺酚市場趨勢

全球乙醯胺酚市場正呈現出向永續包裝解決方案發展的顯著趨勢，這主要得益於各國政府，特別是歐盟和北美地區政府的嚴格監管。這一轉變很大程度上源於消費者環保意識的增強和對環保產品需求的日益成長，促使製藥企業優先考慮環保包裝創新。遵循世界衛生組織（WHO）關於減少藥品廢棄物的建議，各公司正在探索並實施在乙醯胺酚包裝中使用可再生材料。這種轉變不僅符合法規結構，還有助於提升品牌聲譽和消費者忠誠度，使製造商在日益重視永續性的競爭激烈的市場中佔據有利地位。

Johnson & Johnson
GSK Consumer Healthcare
Sanofi
Mallinckrodt Pharmaceuticals
Granules India Limited
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories
Cipla Inc.
Novartis
Pfizer
Abbott Laboratories
Bayer AG
Zydus Lifesciences
Mylan（Viatris）
Aurobindo Pharma
Lupin Limited
Torrent Pharmaceuticals
Glenmark Pharmaceuticals
Alkem Laboratories

結論與建議

簡介目錄

Product Code: SQMIG35I2374

Global Paracetamol Market size was valued at USD 795.21 Million in 2024 and is poised to grow from USD 830.2 Million in 2025 to USD 1171.63 Million by 2033, growing at a CAGR of 4.4% in the forecast period (2026-2033).

The market for global paracetamol is witnessing notable growth driven by the rising preference for self-treatment and an increase in minor health issues like fever, pain, and headaches. Accessibility, coupled with affordability and inclusion as an essential drug, further fuels this trend. Emerging economies are enhancing healthcare infrastructure, improving availability. However, challenges such as stringent regulatory environments and quality concerns affect stakeholders, resulting in higher production costs and extended time-to-market. Issues of improper usage highlight the need for better consumer education and stricter regulations to ensure safety. Despite these obstacles, opportunities arise from formulation innovations, including options with fewer side effects and tailored products. Collaborations and advancements in distribution networks signal potential for sustained market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Paracetamol market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Paracetamol Market Segments Analysis

Global paracetamol market is segmented on the basis of type, formulation, application, end user, distribution channel and region. On the basis of type, the market is divided into acetaminophen grade and veterinary drug grade. On the basis of formulation, the market is divided into others, powder, liquid suspension, capsule and tablet. On the basis of application, the market is divided into other, cold and flu relief, fever management and pain management. By end user, the market has been segmented into hospitals, clinics, homecare, and ambulatory surgical centers. On the basis of distribution channel, the market has been segmented as Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Supermarkets/Hypermarkets. By geography, the market is studied across North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Driver of the Global Paracetamol Market

The global paracetamol market is significantly driven by the increasing prevalence of pain-related conditions such as arthritis, migraines, and back pain. A substantial portion of the adult population experiences chronic pain, highlighting a pressing need for effective pain management solutions. In response to this growing concern, numerous governments and healthcare organizations are advocating for improved accessibility to pain relief options. This emphasis on addressing chronic pain not only elevates the demand for paracetamol but also encourages the development of strategies aimed at enhancing pain control, further boosting the market's growth and expanding its reach across various demographics.

Restraints in the Global Paracetamol Market

The global paracetamol market faces significant constraints due to persistent concerns surrounding overdose risks. Health organizations worldwide, including major regulatory bodies, have raised alarms about the potential for liver failure linked to excessive paracetamol consumption. This alarming association has made overdose one of the leading causes of liver-related health issues. Consequently, this situation has led to more stringent regulations and enhanced safety protocols within the pharmaceutical industry. Companies, such as GlaxoSmithKline, are taking proactive measures in response to these challenges to improve safety standards and mitigate the risks associated with paracetamol use, ultimately influencing market dynamics.

Market Trends of the Global Paracetamol Market

The Global Paracetamol market is witnessing a significant trend towards sustainable packaging solutions, driven by stringent regulations from governments, particularly in the EU and North America. This shift is largely influenced by growing consumer awareness and demand for environmentally friendly products, leading pharmaceutical manufacturers to prioritize eco-conscious packaging innovations. In response to recommendations from the World Health Organization regarding the reduction of pharmaceutical waste, companies are exploring and implementing recyclable materials for paracetamol packaging. This evolution not only aligns with regulatory frameworks but also enhances brand reputation and consumer loyalty, positioning manufacturers favorably in a competitive marketplace increasingly focused on sustainability.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Customer & Buying Criteria Analysis
Patent Analysis

Global Paracetamol Market Size by Type & CAGR (2026-2033)

Market Overview
Veterinary Drug Grade
Acetaminophen Grade

Global Paracetamol Market Size by Formulation & CAGR (2026-2033)

Market Overview
Tablet
Capsule
Liquid Suspension
Powder
Others

Global Paracetamol Market Size by Application & CAGR (2026-2033)

Market Overview
Pain Management
Fever Management
Cold and Flu Relief
Other

Global Paracetamol Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Homecare
Ambulatory Surgical Centers

Global Paracetamol Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Supermarkets/Hypermarkets

Global Paracetamol Market Size & CAGR (2026-2033)

North America (Type, Formulation, Application, End User, Distribution Channel)
- US
- Canada
Europe (Type, Formulation, Application, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Formulation, Application, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Formulation, Application, End User, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Formulation, Application, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK Consumer Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Granules India Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zydus Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan (Viatris)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Torrent Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glenmark Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alkem Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments